Jacqueline Wyatt
55Patents
15h-index
48Co-inventors
80Inventor score
Filing activity: Mar 12, 1993 → Jul 6, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6210892A | Alteration of cellular behavior by antisense modulation of mRNA processing | Emerging Cross-Sectional Technologies | 245 | Expired |
| US7321828B2 | System of components for preparing oligonucleotides | Physics | 177 | Expired |
| US6444464B1 | Antisense modulation of E2F transcription factor 2 expression | Emerging Cross-Sectional Technologies | 113 | Expired |
| US6287860A | Antisense inhibition of MEKK2 expression | Emerging Cross-Sectional Technologies | 103 | Expired |
| US5514577A | Oligonucleotide therapies for modulating the effects of herpes viruses | Chemistry; Metallurgy | 91 | Expired |
| US5523389A | Inhibitors of human immunodeficiency virus | Chemistry; Metallurgy | 53 | Expired |
| US5925732A | Chemical reaction apparatus for performing multiple reaction on a surface and collecting the product | Chemistry; Metallurgy | 48 | Expired |
| US7067497B2 | Modulation of telomere length by oligonucleotides having a G-core sequence | Chemistry; Metallurgy | 47 | Expired |
| US5952490A | Oligonucleotides having a conserved G4 core sequence | Chemistry; Metallurgy | 38 | Expired |
| US6261840A | Antisense modulation of PTP1B expression | Emerging Cross-Sectional Technologies | 34 | Expired |
| US7563884B2 | Antisense modulation of PTP1B expression | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6329203A | Antisense modulation of glioma-associated oncogene-1 expression | Emerging Cross-Sectional Technologies | 21 | Expired |
| US5698391A | Methods for synthetic unrandomization of oligomer fragments | Physics | 20 | Expired |
| US6602857B1 | Antisense modulation of PTP1B expression | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6379960B1 | Antisense modulation of damage-specific DNA binding protein 2, p48 expression | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6265216A | Antisense modulation of cot oncogene expression | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6277334A | Chemical synthesis apparatus employing a droplet generator | Chemistry; Metallurgy | 14 | Expired |
| US6372433B1 | Antisense modulation of inhibitor of DNA binding-1 expression | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6365354B1 | Antisense modulation of lysophospholipase I expression | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6503754B1 | Antisense modulation of BH3 interacting domain death agonist expression | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6306655A | Antisense inhibition of C/EBP alpha expression | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6455307B1 | Antisense modulation of casein kinase 2-alpha prime expression | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6187545A | Antisense modulation of pepck-cytosolic expression | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6323029A | Antisense modulation of glycogen synthase kinase 3 beta expression | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6316259A | Antisense inhibition of glycogen synthase kinase 3 alpha expression | Emerging Cross-Sectional Technologies | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.